PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
2.025
-0.070 (-3.34%)
At close: Nov 20, 2024, 4:00 PM
2.120
+0.095 (4.69%)
Pre-market: Nov 21, 2024, 7:31 AM EST
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $74.56 million as of November 21, 2024. Its market cap has decreased by -48.29% in one year.
Market Cap
74.56M
Enterprise Value
41.20M
1-Year Change
-48.29%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since October 1, 2015, PDS Biotechnology's market cap has decreased from $334.50M to $74.56M, a decrease of -77.71%. That is a compound annual growth rate of -15.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 78.40M | -49.29% |
| Dec 29, 2023 | 154.60M | -58.92% |
| Dec 30, 2022 | 376.30M | 63.40% |
| Dec 31, 2021 | 230.30M | 383.82% |
| Dec 31, 2020 | 47.60M | 211.11% |
| Dec 31, 2019 | 15.30M | 51.49% |
| Dec 31, 2018 | 10.10M | -96.51% |
| Dec 29, 2017 | 289.20M | -20.00% |
| Dec 30, 2016 | 361.50M | 0.39% |
| Dec 31, 2015 | 360.10M | 7.65% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rockwell Medical | 75.95M |
| P3 Health Partners | 75.94M |
| ESSA Pharma | 75.87M |
| Aligos Therapeutics | 74.68M |
| Ovid Therapeutics | 73.85M |
| Aerovate Therapeutics | 73.05M |
| BioAtla | 73.00M |
| Vivani Medical | 72.94M |